Anesthesia for Obese Patients: Desflurane Versus Xenon
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Obesity is increasing in France, resulting in an increased demand for bariatric surgery.
However obesity also alters physiopathological pathways and the pharmacokinetics of
anesthestic agents. The investigators objective is to compare, among morbidly obese patients,
the immediate and intermediary emergence kinetics after balanced anesthesia using
remifentanil associated either with desflurane (reference arm) or with xenon (experimental
arm).